New Zealand’s proportion of reinfections is now at 17% of new cases. As new variants continue to proliferate, vaccine boosters would protect those most vulnerable and reduce the risk of long COVID.
Articles on Long COVID
Displaying 81 - 100 of 148 articles
Exercise doesn’t have to be something very difficult to start off with.
Many people face persistent cognitive symptoms after COVID-19. A new study, which grew and examined 3D models of the human brain, offers a possible explanation as to why this might be.
Start by creating a safe space by showing you beleive them.
We’ve become used to the term ‘brain fog’ in connection to long COVID. But what is it and how do you know if you have it?
How does stress impact the body’s ability to fight infection?
A new paper looks at referrals to a long COVID clinic in England over the past two years. The results are good news.
The increased risks of heart attack and stroke after COVID shown in a recent study, could drive a new pandemic of heart disease over coming years.
Since immunity from COVID vaccination begins to wane over time, it’s important that everyone, irrespective of age, receives their boosters as soon as they are eligible to do so.
We know very little about how long COVID affects the body, and why some people develop ongoing symptoms and others don’t. But emerging evidence offers clues.
As New Zealand emerges from its Omicron wave, increasing hybrid immunity and access to antivirals mean it’s time to shift the focus of COVID management.
A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
A recent study suggests one in eight people who get COVID will go on to develop long COVID.
A good doctor can help you work out when tiredness has crossed over into true fatigue.
Mainstream medicine hasn’t yet found enough evidence-based treatments for long COVID. No wonder sufferers are turning to unproven therapies.
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
Contrary to widely held beliefs, effective therapies exist for post-infection conditions like long COVID. But we’ll need to come to terms with our history to make a difference for sufferers.
Face masks are still an effective way to help stop the spread of the BA.5 subvariant.
Long COVID sufferers may have experienced a wider variety of symptoms than previously thought, new research has found.
Long COVID patients are taking desperate measures in the hope of getting better. It’s time to increase our focus on testing potential long COVID treatments in clinical trials.
Top contributors
-
Professor of Public Health, Te Kunenga ki Pūrehuroa – Massey University
-
Research Associate Professor of Public Health, University of Otago
-
Professor of Public Health, University of Southampton
-
Professor of Public Health, University of Otago
-
Senior Research Fellow, The Perron Institute for Neurological and Translational Science, and Faculty of Health Sciences, Curtin University
-
Director and CEO, Burnet Institute
-
Professor of Immunology, RMIT University
-
Associate Professor, STEM | Health and Biomedical Sciences, RMIT University
-
Conjoint Professor, School of Medicine and Public Health, University of Newcastle
-
Clinical Epidemiologist, Washington University in St. Louis
-
Professor of Genomic Epidemiology and Hon Consultant Rheumatologist, King's College London
-
Research Fellow, The University of Western Australia
-
SHARP Professor, Vitalities Lab, Centre for Social Research in Health and Social Policy Centre, and the ARC Centre of Excellence for Automated Decision-Making and Society, UNSW
-
Associate Professor, Child and Adolescent Health, University of Sydney
-
Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute